Quick Links

 Selected Publications

Vora, N.: External beam and interstitial implant radiotherapy as primary management for early breast cancer.  City of Hope Quarterly Report 12(3):6-9, 1983.
 
Vora, N.L.: Alternatives to mastectomy.  City of Hope Quarterly Report 12(3):3-5, Spring 1983.

Peer Review Publications
 
Snyder, D., Stein, A., Pullarkat, V., Sahebi, F., Cohen, S., Palmer, J., Vora, N., Nakamura, R., and Forman, S.: Allogeneic Hematopoietic Cell Transplantation Following Reduced-Intensity Conditioning for Treatment of Myelofibrosis, approved for publication in BBMT 2006.

Stein, A., O’Donnell, M., Parker, P., Spielberger, R., Nademanee, A., Bhatia, R., Snyder, D., Kirschbaum, M., Pullarkat, V., Kogut, N., Bolotin, E., Chang, K., Sarkodee-Adoo, C., Slovak, M., Vora, N., Land, J., RN, Dagis, A., Palmer, J., and Forman, S.: Analysis of Long Term Outcome in Autologous Stem Cell Transplant (ASCT) for Acute Myelogenous Leukemia (AML) in First Remission (CR1)- A 15 year experience., City of Hope.

Pezner, R., Vora, N., Frankel, P., Chen, Y., Shen, J., Paz, B.: Breast Retraction Assessment (BRA) of Cosmetic Fibrotic Changes in Patients Undergoing Partial Breast Irradiation: Baseline and Short-term Follow-up Quantitive Measurements, City of Hope.

Chen, Y., Liu, A., Tsai, P., Vora, N., Pezner, R., Schultheiss, T., Wong, J. : Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: Dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes.  Int. J. Radiation Oncology Biol. Phys., Vol. 63, No. 1, pp. 274-281, 2005.

Adoo, C., Stein, A., O’Donnell, M., Bhatia, R., Bolotin, E., Chan, K., Kirschbaum, M., Kogut, N., Nademanee, A., Parker, P., Pullarkat, V., Snyder, D., Spielberger, R., Slovak, M., Alvarnas, J., Fridey, J., Schriber, J., Smith, E., Dagis, A., Land, J., Palmer, J., Vora, N., Forman, S.: Long term survival after ASCT for AML: Multivariate analysis shows adverse effect of collecting and infusing larger numbers of CD 34 positive cells.  Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center.

Pameijer, C., Shultz, J., Vora, N., Vora, N., Shibata, S., Wagman, L., Ellenhorn, J., Paz, B.:  Neoadjuvant Chemotherapy in Patients with Advanced Non-Laryngeal Squamous Cell Carcinoma of the Head and Neck Permits Limited Resection, 6th International Conference on Head & Neck Cancers, August 11, 2004.

Fung, H., Cohen, S., Dagis A., O’Donnell, M., Falk, P., Kogut, N., Krishnan, A., Molina, A., Nademanee, A., Parker, P., Popplewell, L., Rodriguez, R., Slovak, M., Sahebi, F., Smith D., Spielberger, R., Stein, A., Snyder, D., Vora, N., Wong, K., Bhatia, S., Bhatia, G., Somlo, G., Forman, S., Div. Of Hem/BMT, City of Hope Cancer Center, Duarte, CA, USA; BMT Program, Kaiser Permanente- City of Hope, Duarte, CA, USA.: Long term Follow-Up Report on Allogeneic Stem Cell Transplantation (alloSCT) for Patients with Acute Myelogenous Leukemia (AML) in First Relapse (rel) or 2nd Complete Remission (CR): Analysis of Prognostic Factors.  Abstracts of the 44th Annual Meeting of the American Society of Hematology Support/Disclosure, Page 1, December 6-10, 2002, Convention Center, Philadelphia, Pennsylvania.

Fung, H., Wang, S., Nademanee, A., Cohen, S., O’Donnell, M., Falk, P., Kogut, N., Krishnan, A., Molina, A., Parker, P., Popplewell, L., Rodriguez, R., Sahebi, F., Smith, D., Snyder, D., Stein, S., Speilberger, R., Bhatia, R., Bhatia, S., Somlo, G., Vora, N., Forman, S.J., Div. Of Hematology/BMT, City of Hope Cancer Center, Duarte, CA, USA; BMT Program, Kaiser Permanente-City of Hope, Duarte, CA, USA.: Autologous Peripheral Stem Cell Transplantation (ABSCT) for Adult Patients with Hodgkin’s Disease (HD): Impact of Mobilization Kinetics on Transplant Outcome.  Abstracts of the 44th Annual Meeting of the American Society of Hematology Support/Disclosure, Page 1, Dec. 6-10, 2002, Convention Center, Philadelphia, Pennsylvania.

Fung, H., Nademanee, A., Molina, A., Ruel, C., Ivers, B., Smith, D., Krishnan, A., Popplewell, L., Vora, N., Snyder, D., O’Donnell, M., Parker, P., Stein, A., Somlo, G., Falk, P., Kogut, N., Spielberger, R., Rodriguez, R., Rosenthal, J., Schriber, J., Bhatia, R., Bhatia, S., Alvarnas, J., Sweetman, R., Cohen, S., Sahebi, F., Forman, S.J.: Autologous Stem Cell Transplantation (ASCT) in 100 Patients with Hodgkin’s Disease (HD) in First Relapse (1st Rel): Impact of (FTBI)-Based Versus BCNU-Based] on the Patterns of Treatment Failure.  Journal of the American Society of Hematology Forty-third Annual Meeting, December 7-11, 2001, page 678a.

Fung, H., O’Donnell, M., Popplewell, L., Stein, A., Nademanee, A., Parker, A., Slovak, M.L., Molina, A., Smith, D., Gilfillan, K., Snyder, D., Krishnan, A., Rodriguez, R., Somlo, G., Kogut, N., Falk, P., Speilberger, R., Sahebi, F., Rosenthal, J., Vora, N., Cohen, S., Bhatia, R., Bhatia, S., Sweetman, R., Schriber, J., Alvarnas, J., Cui, K., Forman, S.J.: Allogeneic Stem Cell Transplantation (SCT) for Patients with Primary Refractory Acute Myelogenous Leukemia (AML): Impact of Cytogenetic Risk Group on the Transplant Outcome.   Journal of the American Society of Hematology Forty-third Annual Meeting December 7-11, 2001, page 483a.

Vora, N., Paz, B., Shibata, S., Ellenhorn, J.D.I., Pezner, R.D., Wong, J., and Wagman, L.D.:  Neoadjuvant chemotherapy, radiation treatment, and  functional surgery in advanced head and neck cancer.  ICACT 10th International Congress on Anti-Cancer Treatment, January 31 to February 3, 2000.


This is a partial list. Full publication list available upon request. Information on this page may be self-reported and subject to change at any time. Last updated: 10/08. 

 Search

Go!
Advanced Search Options
News & Publications Search
NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.